Retrospective review of 185 hospitalized AOSD pts (incidence 0.16 - 0.21/100K); Mean age 47 (70% female), mean ESR 55, C

Tweet Author

Tweet Content

Retrospective review of 185 hospitalized AOSD pts (incidence 0.16 - 0.21/100K); Mean age 47 (70% female), mean ESR 55, CRP 12.26, ferritin 7141 WBC 12.15, anemia 23%. 24% ICU care & overall mortality was 3.2%. Ab#0829 #ACR22 https://t.co/eDRY4b3GAg https://t.co/3pt0ZH5QQH

Links

https://bit.ly/3tKKxIC

Best of PsA on Day 1 Dr. Rachel Tate ( @uptoTate) discusses the best PSA data presented 11/12 at #ACR22 https://t.c

Tweet Author

RheumNow

Tweet Content

Best of PsA on Day 1 Dr. Rachel Tate ( @uptoTate) discusses the best PSA data presented 11/12 at #ACR22 https://t.co/i93CX7wic3 https://t.co/dQDOcIsu1P

Links

https://bit.ly/3TIoZXu

#ACR22 - Day 2 Part III RheumNow and its reporters review abstracts presented on Day 2 of #ACR22. https://t.co/uUiX7s5

Tweet Author

RheumNow

Tweet Content

#ACR22 - Day 2 Part III RheumNow and its reporters review abstracts presented on Day 2 of #ACR22. https://t.co/uUiX7s5Ajf https://t.co/0E5KSpOyyL

Links

https://bit.ly/3EKEMAE

Survival and Mortality in RA: time to move away from âone-size fits allâ? Dr. Aurelie Najm ( @AurelieRheumo ) revi

Tweet Author

RheumNow

Tweet Content

Survival and Mortality in RA: time to move away from “one-size fits all”? Dr. Aurelie Najm ( @AurelieRheumo ) reviews Abstract #0246 at #ACR22. https://t.co/O4dNzCZmmd https://t.co/cWUXEpduID

Links

https://bit.ly/3Eh0qeF

Exciting Data for SLE: Plenaries from #ACR22 Dr. Michael Putman ( @EBRheum ) shares SLE updates shared at #ACR22. ht

Tweet Author

RheumNow

Tweet Content

Exciting Data for SLE: Plenaries from #ACR22 Dr. Michael Putman ( @EBRheum ) shares SLE updates shared at #ACR22. https://t.co/34HAvc2S8F https://t.co/xINo52fF2O

Links

https://bit.ly/3En9DSH

Can computers tell the difference between RA & PsA? Dr. David Liew ( @drdavidliew) discusses Abstract 0242 present

Tweet Author

RheumNow

Tweet Content

Can computers tell the difference between RA & PsA? Dr. David Liew ( @drdavidliew) discusses Abstract 0242 presented at #ACR22. Abstract 0242: Neural Networks for Distinguishing RA from PsA by Using Magnetic Resonance Imaging https://t.co/ZL5TYIdT6Q https://t.co/tZWIAl0rb0

Links

https://bit.ly/3EcS9bm

Upadacitinib vs Adalimumab in PsA using RAPID3 Dr. Catherine Sims ( @DrCassySims) discusses abstract 0192 presented at

Tweet Author

RheumNow

Tweet Content

Upadacitinib vs Adalimumab in PsA using RAPID3 Dr. Catherine Sims ( @DrCassySims) discusses abstract 0192 presented at #ACR22. 0192: Upadacitinib versus Adalimumab on Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with PsA, https://t.co/nRjgM45GdO https://t.co/MDqpW7ACXa

Links

https://bit.ly/3EkUcdD

#ACR22 Rheumatology Roundup w/ Drs. Kavanaugh & Cush #1044 Combo Rx SpA #0533 CCP spit #1604 StopRA #2251 Tofa &

Tweet Author

RheumNow

Tweet Content

#ACR22 Rheumatology Roundup w/ Drs. Kavanaugh & Cush #1044 Combo Rx SpA #0533 CCP spit #1604 StopRA #2251 Tofa & RA ILD #0420 NSAID SpA #002 CA in IIM #0113 BTK Sjogrens #L05 Prolia EOA #0526 Pexivas #1106 TCZ PMR Video: https://t.co/JG3spEsYDD Podcast: https://t.co/nbmeiGo2yt https://t.co/E7RDPTFsaS

Links

https://bit.ly/3EJTVCz

https://bit.ly/3hTRNiC

Urinary Biomarkers in Lupus Dr.Cush interviews Dr. Fava about Abstract 536 at #ACR22. Abstract 0536: Change in Urinary

Tweet Author

RheumNow

Tweet Content

Urinary Biomarkers in Lupus Dr.Cush interviews Dr. Fava about Abstract 536 at #ACR22. Abstract 0536: Change in Urinary Biomarkers at Three Months Predicts 1-year Treatment Response of Lupus Nephritis Better Than Proteinuria https://t.co/3IfPdTMufb https://t.co/XVECG9mJri

Links

https://bit.ly/3EK5Os2

18 November 2022

Why treatment of pre-RA isn't ready for prime time

The ACR Great Debate was on "To treat or not to treat in pre-RA?". What is the clinician to do?

Topics

Retrospective review of 185 hospitalized AOSD pts (incidence 0.16 - 0.21/100K); Mean age 47 (70% female), mean ESR 55, C

Best of PsA on Day 1 Dr. Rachel Tate ( @uptoTate) discusses the best PSA data presented 11/12 at #ACR22 https://t.c

#ACR22 - Day 2 Part III RheumNow and its reporters review abstracts presented on Day 2 of #ACR22. https://t.co/uUiX7s5

Survival and Mortality in RA: time to move away from âone-size fits allâ? Dr. Aurelie Najm ( @AurelieRheumo ) revi

Exciting Data for SLE: Plenaries from #ACR22 Dr. Michael Putman ( @EBRheum ) shares SLE updates shared at #ACR22. ht

Can computers tell the difference between RA & PsA? Dr. David Liew ( @drdavidliew) discusses Abstract 0242 present

Upadacitinib vs Adalimumab in PsA using RAPID3 Dr. Catherine Sims ( @DrCassySims) discusses abstract 0192 presented at

#ACR22 Rheumatology Roundup w/ Drs. Kavanaugh & Cush #1044 Combo Rx SpA #0533 CCP spit #1604 StopRA #2251 Tofa &

Urinary Biomarkers in Lupus Dr.Cush interviews Dr. Fava about Abstract 536 at #ACR22. Abstract 0536: Change in Urinary

Do you get our email newsletter?

Retrospective review of 185 hospitalized AOSD pts (incidence 0.16 - 0.21/100K); Mean age 47 (70% female), mean ESR 55, C

Best of PsA on Day 1 Dr. Rachel Tate ( @uptoTate) discusses the best PSA data presented 11/12 at #ACR22 https://t.c

#ACR22 - Day 2 Part III RheumNow and its reporters review abstracts presented on Day 2 of #ACR22. https://t.co/uUiX7s5

Survival and Mortality in RA: time to move away from âone-size fits allâ? Dr. Aurelie Najm ( @AurelieRheumo ) revi

Exciting Data for SLE: Plenaries from #ACR22 Dr. Michael Putman ( @EBRheum ) shares SLE updates shared at #ACR22. ht

Can computers tell the difference between RA &amp; PsA? Dr. David Liew ( @drdavidliew) discusses Abstract 0242 present

Upadacitinib vs Adalimumab in PsA using RAPID3 Dr. Catherine Sims ( @DrCassySims) discusses abstract 0192 presented at

#ACR22 Rheumatology Roundup w/ Drs. Kavanaugh &amp; Cush #1044 Combo Rx SpA #0533 CCP spit #1604 StopRA #2251 Tofa &amp;

Urinary Biomarkers in Lupus Dr.Cush interviews Dr. Fava about Abstract 536 at #ACR22. Abstract 0536: Change in Urinary

Survival and Mortality in RA: time to move away from âone-size fits allâ? Dr. Aurelie Najm ( @AurelieRheumo ) revi

Can computers tell the difference between RA & PsA? Dr. David Liew ( @drdavidliew) discusses Abstract 0242 present

#ACR22 Rheumatology Roundup w/ Drs. Kavanaugh & Cush #1044 Combo Rx SpA #0533 CCP spit #1604 StopRA #2251 Tofa &